{"transactions":[{"id":2304637,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-05T22:52:55.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":2500,"price":52.1092,"value":130273.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.85 to $52.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1175589,"source":{"system":"sec-edgar","filing":"0001725160-22-000068","document":"wf-form4_164919916054278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000068/wf-form4_164919916054278.xml","form_type":"4"}},{"id":2304636,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-05T22:52:55.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":7971,"price":51.3362,"value":409200.8502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.84 to $51.83. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1178089,"source":{"system":"sec-edgar","filing":"0001725160-22-000068","document":"wf-form4_164919916054278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000068/wf-form4_164919916054278.xml","form_type":"4"}},{"id":2304635,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-05T22:52:55.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":10471,"price":48.5,"value":507843.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."}],"balance_after":1186060,"source":{"system":"sec-edgar","filing":"0001725160-22-000068","document":"wf-form4_164919916054278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000068/wf-form4_164919916054278.xml","form_type":"4"}},{"id":2354836,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-03T22:11:19.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":700,"price":50.9137,"value":35639.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.55 to $51.45. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1196531,"source":{"system":"sec-edgar","filing":"0001725160-22-000055","document":"wf-form4_164634545383161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000055/wf-form4_164634545383161.xml","form_type":"4"}},{"id":2354835,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-03T22:11:19.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":9771,"price":50.1101,"value":489625.7871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.54 to $50.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1197231,"source":{"system":"sec-edgar","filing":"0001725160-22-000055","document":"wf-form4_164634545383161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000055/wf-form4_164634545383161.xml","form_type":"4"}},{"id":2354834,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-03T22:11:19.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1700,"price":50.0506,"value":85086.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.98 to $50.48. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1207002,"source":{"system":"sec-edgar","filing":"0001725160-22-000055","document":"wf-form4_164634545383161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000055/wf-form4_164634545383161.xml","form_type":"4"}},{"id":2354833,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-03T22:11:19.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":8771,"price":49.7432,"value":436297.6072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $48.97 to $49.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1208702,"source":{"system":"sec-edgar","filing":"0001725160-22-000055","document":"wf-form4_164634545383161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000055/wf-form4_164634545383161.xml","form_type":"4"}},{"id":2398183,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T02:08:28.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":118319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":118319,"derivative":{"exercise_price":52.61,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":118319},"source":{"system":"sec-edgar","filing":"0001725160-22-000031","document":"wf-form4_164489087350121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000031/wf-form4_164489087350121.xml","form_type":"4"}},{"id":2398182,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-15T02:08:28.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":525,"price":50.7472,"value":26642.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1217473,"source":{"system":"sec-edgar","filing":"0001725160-22-000031","document":"wf-form4_164489087350121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000031/wf-form4_164489087350121.xml","form_type":"4"}},{"id":2398181,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-15T02:08:28.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":4208,"price":50.1642,"value":211090.9536,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1217998,"source":{"system":"sec-edgar","filing":"0001725160-22-000031","document":"wf-form4_164489087350121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000031/wf-form4_164489087350121.xml","form_type":"4"}},{"id":2398180,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-15T02:08:28.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":50431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":1222206,"source":{"system":"sec-edgar","filing":"0001725160-22-000031","document":"wf-form4_164489087350121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000031/wf-form4_164489087350121.xml","form_type":"4"}},{"id":2414109,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T01:03:41.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":2343,"price":58.2923,"value":136578.8589,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $58.16 to $58.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1171775,"source":{"system":"sec-edgar","filing":"0001725160-22-000017","document":"wf-form4_164393660436349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000017/wf-form4_164393660436349.xml","form_type":"4"}},{"id":2414108,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T01:03:41.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":8128,"price":57.8724,"value":470386.8672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $57.16 to $58.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1174118,"source":{"system":"sec-edgar","filing":"0001725160-22-000017","document":"wf-form4_164393660436349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000017/wf-form4_164393660436349.xml","form_type":"4"}},{"id":2414107,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T01:03:41.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":100,"price":59.31,"value":5931.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."}],"balance_after":1182246,"source":{"system":"sec-edgar","filing":"0001725160-22-000017","document":"wf-form4_164393660436349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000017/wf-form4_164393660436349.xml","form_type":"4"}},{"id":2414106,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T01:03:41.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":2828,"price":58.5872,"value":165684.6016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $58.24 to $59.21. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1182346,"source":{"system":"sec-edgar","filing":"0001725160-22-000017","document":"wf-form4_164393660436349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000017/wf-form4_164393660436349.xml","form_type":"4"}},{"id":2414105,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T01:03:41.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":3419,"price":57.6273,"value":197027.7387,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $57.21 to $58.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1185174,"source":{"system":"sec-edgar","filing":"0001725160-22-000017","document":"wf-form4_164393660436349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000017/wf-form4_164393660436349.xml","form_type":"4"}},{"id":2414104,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T01:03:41.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":4124,"price":56.8096,"value":234282.7904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $56.21 to $57.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1188593,"source":{"system":"sec-edgar","filing":"0001725160-22-000017","document":"wf-form4_164393660436349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000017/wf-form4_164393660436349.xml","form_type":"4"}},{"id":2444142,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":44,"price":80.4297,"value":3538.9068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.35 to $80.725. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1192717,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444141,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":1556,"price":79.5416,"value":123766.7296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.26 to $80.13. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1192761,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444140,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":6871,"price":78.7571,"value":541140.0341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.24 to $79.23. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1194317,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444139,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":2000,"price":77.7123,"value":155424.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.23 to $78.14. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1201188,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444138,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":300,"price":83.8933,"value":25167.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $83.34 to $84.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1203188,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444137,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":993,"price":82.1795,"value":81604.2435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $81.91 to $82.73. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1203488,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444136,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1108,"price":81.1391,"value":89902.1228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.79 to $81.40. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1204481,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444135,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":4372,"price":80.3565,"value":351318.618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.78 to $80.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1205589,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444134,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1125,"price":79.1848,"value":89082.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.73 to $79.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1209961,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444133,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":2573,"price":78.2596,"value":201361.9508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.72 to $78.71. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1211086,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2444132,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T22:49:49.000Z","date":"2021-12-16","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1213659,"source":{"system":"sec-edgar","filing":"0001725160-22-000006","document":"wf-form4_164142297445637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000006/wf-form4_164142297445637.xml","form_type":"4"}},{"id":2482344,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-08T01:35:40.000Z","date":"2021-11-26","kind":"gift","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person's original Form 4 filed on December 2, 2021 contained an error in the form of ownership of the Common Stock gifted to the Hao Jiao Zi Trust LLC by the Reporting Person's spouse on November 26, 2021, and mistakenly indicated that these shares were gifted by the Reporting Person directly. This Form 4/A corrects the error and presents the correct number of shares of common stock beneficially owned by the Reporting Person's spouse and by the Reporting Person directly following the reported transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person's original Form 4 filed on December 2, 2021 contained an error in the form of ownership of the Common Stock gifted to the Hao Jiao Zi Trust LLC by the Reporting Person's spouse on November 26, 2021, and mistakenly indicated that these shares were gifted by the Reporting Person directly. This Form 4/A corrects the error and presents the correct number of shares of common stock beneficially owned by the Reporting Person's spouse and by the Reporting Person directly following the reported transaction."}],"balance_after":103650,"source":{"system":"sec-edgar","filing":"0001725160-21-000236","document":"wf-form4a_163892732690586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000236/wf-form4a_163892732690586.xml","form_type":"4/A","original_submission_date":"2021-12-02"}},{"id":2488849,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":124,"price":78.8494,"value":9777.3256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.77 to $79.18. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1103659,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488848,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":3823,"price":77.9672,"value":298068.6056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.74 to $78.40. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1103783,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488847,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":3824,"price":77.3565,"value":295811.256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.72 to $77.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1107606,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488846,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":500,"price":75.99,"value":37995.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.62 to $76.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1111430,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488845,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":600,"price":74.6818,"value":44809.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $74.45 to $75.29. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1111930,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488844,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":1289,"price":73.6235,"value":94900.6915,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.23 to $74.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1112530,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488843,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":311,"price":72.7646,"value":22629.7906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.12 to $73.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1113819,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488842,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":104,"price":81.12,"value":8436.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."}],"balance_after":1114130,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488841,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2700,"price":80.3215,"value":216868.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.11 to $80.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1114234,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488840,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":3502,"price":79.6536,"value":278946.9072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.10 to $80.08. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1116934,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488839,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":396,"price":78.5934,"value":31122.9864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.07 to $79.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1120436,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488838,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":500,"price":77.0924,"value":38546.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.81 to $77.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1120832,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488837,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":800,"price":75.8463,"value":60677.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.34 to $76.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1121332,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488836,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":921,"price":74.2343,"value":68369.7903,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.91 to $74.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1122132,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488835,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":1548,"price":73.3644,"value":113568.0912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.91 to $73.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1123053,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488834,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-11-26","kind":"gift","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hao Jiao Zi Trust LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares nominally held by Hao Jiao Zi Trust LLC on behalf of the Hao Jiao Zi Trust (the \"Trust\"), the sole member of Hao Jiao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Jiao Zi Trust LLC except to the extent of his pecuniary interest therein, if any."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2488833,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-03T00:16:54.000Z","date":"2021-11-26","kind":"gift","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1124601,"source":{"system":"sec-edgar","filing":"0001725160-21-000232","document":"wf-form4_163849059249724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000232/wf-form4_163849059249724.xml","form_type":"4"}},{"id":2500253,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-22T09:16:47.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":9653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":9653,"derivative":{"exercise_price":3.59,"expiration_date":"2031-11-17","underlying":"Common Stock","underlying_shares":9653},"source":{"system":"sec-edgar","filing":"0001415889-21-005363","document":"form4-11222021_061140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377952/000141588921005363/form4-11222021_061140.xml","form_type":"4"}},{"id":2500252,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2021-11-22T09:16:47.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":6963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":26322,"source":{"system":"sec-edgar","filing":"0001415889-21-005363","document":"form4-11222021_061140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377952/000141588921005363/form4-11222021_061140.xml","form_type":"4"}},{"id":2529030,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":3797,"price":81.0978,"value":307928.3466,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.81 to $81.44. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1249601,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2529029,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":5180,"price":80.3186,"value":416050.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.81 to $80.80. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1253398,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2529028,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":1494,"price":79.4001,"value":118623.7494,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.78 to $79.76. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1258578,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2529027,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":200,"price":83.185,"value":16637.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $83.13 to $83.24. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1260072,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2529026,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":2600,"price":82.4853,"value":214461.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $82.05 to $82.97. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1260272,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2529025,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":3251,"price":81.4756,"value":264877.1756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $81.03 to $82.01. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1262872,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2529024,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T23:24:42.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":4420,"price":80.723,"value":356795.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.03 to $81.02. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1266123,"source":{"system":"sec-edgar","filing":"0001725160-21-000211","document":"wf-form4_163589546612485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000211/wf-form4_163589546612485.xml","form_type":"4"}},{"id":2552158,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T01:15:48.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":27,"price":67.15,"value":1813.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."}],"balance_after":1270543,"source":{"system":"sec-edgar","filing":"0001725160-21-000198","document":"wf-form4_163339651954978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000198/wf-form4_163339651954978.xml","form_type":"4"}},{"id":2552157,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T01:15:48.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":16308,"price":66.5782,"value":1085757.2856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $66.15 to $67.09. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1270570,"source":{"system":"sec-edgar","filing":"0001725160-21-000198","document":"wf-form4_163339651954978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000198/wf-form4_163339651954978.xml","form_type":"4"}},{"id":2552156,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T01:15:48.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":10464,"price":65.9534,"value":690136.3776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $65.15 to $66.14. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1286878,"source":{"system":"sec-edgar","filing":"0001725160-21-000198","document":"wf-form4_163339651954978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000198/wf-form4_163339651954978.xml","form_type":"4"}},{"id":2581755,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-02T23:32:10.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":825,"price":68.5827,"value":56580.7275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $68.53 to $68.59. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1297342,"source":{"system":"sec-edgar","filing":"0001725160-21-000190","document":"wf-form4_163062551581670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000190/wf-form4_163062551581670.xml","form_type":"4"}},{"id":2581754,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-02T23:32:10.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":13482,"price":67.8186,"value":914330.3652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $67.43 to $68.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1298167,"source":{"system":"sec-edgar","filing":"0001725160-21-000190","document":"wf-form4_163062551581670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000190/wf-form4_163062551581670.xml","form_type":"4"}},{"id":2581753,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-02T23:32:10.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":12487,"price":67.0942,"value":837805.2754,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $66.41 to $67.40. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1311649,"source":{"system":"sec-edgar","filing":"0001725160-21-000190","document":"wf-form4_163062551581670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000190/wf-form4_163062551581670.xml","form_type":"4"}},{"id":2617852,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":607,"price":51.3563,"value":31173.2741,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.31 to $51.39. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1324136,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2617851,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":4659,"price":50.704,"value":236229.936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.30 to $51.25. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1324743,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2617850,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":2513,"price":50.0145,"value":125686.4385,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.30 to $50.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1329402,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2617849,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":927,"price":53.1441,"value":49264.5807,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.78 to $53.37. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1331915,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2617848,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":2006,"price":52.2871,"value":104887.9226,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.75 to $52.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1332842,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2617847,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":9182,"price":51.2985,"value":471022.827,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.73 to $51.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1334848,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2617846,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-04T00:01:17.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":6900,"price":50.0104,"value":345071.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.57 to $50.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1344030,"source":{"system":"sec-edgar","filing":"0001725160-21-000176","document":"wf-form4_162803520388448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000176/wf-form4_162803520388448.xml","form_type":"4"}},{"id":2638142,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-08T20:56:20.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":5940,"price":47.7626,"value":283709.844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.56 to $48.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1350930,"source":{"system":"sec-edgar","filing":"0001725160-21-000170","document":"wf-form4_162577775558750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000170/wf-form4_162577775558750.xml","form_type":"4"}},{"id":2638141,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-08T20:56:20.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":7265,"price":47.2801,"value":343489.9265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.55 to $47.54. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1356870,"source":{"system":"sec-edgar","filing":"0001725160-21-000170","document":"wf-form4_162577775558750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000170/wf-form4_162577775558750.xml","form_type":"4"}},{"id":2638140,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-08T20:56:20.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":4599,"price":46.0784,"value":211914.5616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $45.52 to $46.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1364135,"source":{"system":"sec-edgar","filing":"0001725160-21-000170","document":"wf-form4_162577775558750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000170/wf-form4_162577775558750.xml","form_type":"4"}},{"id":2638139,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-08T20:56:20.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":377,"price":48.8341,"value":18410.4557,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $48.11 to $49.01. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1368734,"source":{"system":"sec-edgar","filing":"0001725160-21-000170","document":"wf-form4_162577775558750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000170/wf-form4_162577775558750.xml","form_type":"4"}},{"id":2638138,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-08T20:56:20.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":5320,"price":47.1668,"value":250927.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.08 to $48.07. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1369111,"source":{"system":"sec-edgar","filing":"0001725160-21-000170","document":"wf-form4_162577775558750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000170/wf-form4_162577775558750.xml","form_type":"4"}},{"id":2638137,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-08T20:56:20.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":19348,"price":46.7826,"value":905149.7448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.08 to $47.06. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1374431,"source":{"system":"sec-edgar","filing":"0001725160-21-000170","document":"wf-form4_162577775558750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000170/wf-form4_162577775558750.xml","form_type":"4"}},{"id":2641375,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-07T00:00:46.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":900,"price":53.2039,"value":47883.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $53.09 to $53.43. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1393779,"source":{"system":"sec-edgar","filing":"0001725160-21-000162","document":"wf-form4_162561601212116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000162/wf-form4_162561601212116.xml","form_type":"4"}},{"id":2641374,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-07T00:00:46.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":5180,"price":52.1952,"value":270371.136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.78 to $52.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1394679,"source":{"system":"sec-edgar","filing":"0001725160-21-000162","document":"wf-form4_162561601212116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000162/wf-form4_162561601212116.xml","form_type":"4"}},{"id":2641373,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-07T00:00:46.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":13365,"price":51.2733,"value":685267.6545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.69 to $51.65. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1399859,"source":{"system":"sec-edgar","filing":"0001725160-21-000162","document":"wf-form4_162561601212116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000162/wf-form4_162561601212116.xml","form_type":"4"}},{"id":2641372,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-07-07T00:00:46.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":7349,"price":50.1718,"value":368712.5582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.61 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1413224,"source":{"system":"sec-edgar","filing":"0001725160-21-000162","document":"wf-form4_162561601212116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000162/wf-form4_162561601212116.xml","form_type":"4"}},{"id":2686700,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-03T00:26:00.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2918,"price":54.7179,"value":159666.8322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $54.44 to $55.36. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1420573,"source":{"system":"sec-edgar","filing":"0001725160-21-000134","document":"wf-form4_162267993674438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000134/wf-form4_162267993674438.xml","form_type":"4"}},{"id":2686699,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-03T00:26:00.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":23876,"price":53.9459,"value":1288012.3084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $53.44 to $54.43. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1423491,"source":{"system":"sec-edgar","filing":"0001725160-21-000134","document":"wf-form4_162267993674438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000134/wf-form4_162267993674438.xml","form_type":"4"}},{"id":2727442,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:27:52.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":16823,"price":60.0672,"value":1010510.5056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $59.71 to $60.45. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1447367,"source":{"system":"sec-edgar","filing":"0001725160-21-000121","document":"wf-form4_162024645809800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000121/wf-form4_162024645809800.xml","form_type":"4"}},{"id":2727441,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:27:52.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":2200,"price":59.3658,"value":130604.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $58.70 to $59.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1464190,"source":{"system":"sec-edgar","filing":"0001725160-21-000121","document":"wf-form4_162024645809800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000121/wf-form4_162024645809800.xml","form_type":"4"}},{"id":2727440,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:27:52.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":5182,"price":58.0291,"value":300706.7962,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $57.54 to $58.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1466390,"source":{"system":"sec-edgar","filing":"0001725160-21-000121","document":"wf-form4_162024645809800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000121/wf-form4_162024645809800.xml","form_type":"4"}},{"id":2727439,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:27:52.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":2589,"price":57.0427,"value":147683.5503,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $56.54 to $57.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1471572,"source":{"system":"sec-edgar","filing":"0001725160-21-000121","document":"wf-form4_162024645809800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000121/wf-form4_162024645809800.xml","form_type":"4"}},{"id":2727438,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:27:52.000Z","date":"2021-04-21","kind":"gift","acquired":true,"shares":228650,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":228650,"source":{"system":"sec-edgar","filing":"0001725160-21-000121","document":"wf-form4_162024645809800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000121/wf-form4_162024645809800.xml","form_type":"4"}},{"id":2727437,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:27:52.000Z","date":"2021-04-21","kind":"gift","acquired":false,"shares":228650,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1474161,"source":{"system":"sec-edgar","filing":"0001725160-21-000121","document":"wf-form4_162024645809800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000121/wf-form4_162024645809800.xml","form_type":"4"}},{"id":2755857,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-06T21:40:58.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":224,"price":45.0606,"value":10093.5744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $44.87 to $45.11. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1702811,"source":{"system":"sec-edgar","filing":"0001725160-21-000088","document":"wf-form4_161774514967821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000088/wf-form4_161774514967821.xml","form_type":"4"}},{"id":2755856,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-06T21:40:58.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":400,"price":44.2148,"value":17685.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $43.87 to $44.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1703035,"source":{"system":"sec-edgar","filing":"0001725160-21-000088","document":"wf-form4_161774514967821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000088/wf-form4_161774514967821.xml","form_type":"4"}},{"id":2755855,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-06T21:40:58.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":37144,"price":43.3657,"value":1610775.5608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $42.87 to $43.78. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1703435,"source":{"system":"sec-edgar","filing":"0001725160-21-000088","document":"wf-form4_161774514967821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000088/wf-form4_161774514967821.xml","form_type":"4"}},{"id":2755854,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-06T21:40:58.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":600,"price":45.0558,"value":27033.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $44.99 to $45.11. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1740579,"source":{"system":"sec-edgar","filing":"0001725160-21-000088","document":"wf-form4_161774514967821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000088/wf-form4_161774514967821.xml","form_type":"4"}},{"id":2755853,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-06T21:40:58.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":2300,"price":44.2491,"value":101772.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $43.88 to $44.87. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1741179,"source":{"system":"sec-edgar","filing":"0001725160-21-000088","document":"wf-form4_161774514967821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000088/wf-form4_161774514967821.xml","form_type":"4"}},{"id":2755852,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-06T21:40:58.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":23894,"price":43.3765,"value":1036438.091,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $42.87 to $43.84. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1743479,"source":{"system":"sec-edgar","filing":"0001725160-21-000088","document":"wf-form4_161774514967821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000088/wf-form4_161774514967821.xml","form_type":"4"}},{"id":2814150,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:37:00.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":19195,"price":41.9224,"value":804700.468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."}],"balance_after":1767373,"source":{"system":"sec-edgar","filing":"0001725160-21-000052","document":"wf-form4_161480738876736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000052/wf-form4_161480738876736.xml","form_type":"4"}},{"id":2814149,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:37:00.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":7599,"price":41.127,"value":312524.073,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."}],"balance_after":1786568,"source":{"system":"sec-edgar","filing":"0001725160-21-000052","document":"wf-form4_161480738876736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000052/wf-form4_161480738876736.xml","form_type":"4"}},{"id":2859330,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T00:02:18.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":131250,"derivative":{"exercise_price":38.76,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001725160-21-000038","document":"wf-form4_161352010527706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000038/wf-form4_161352010527706.xml","form_type":"4"}},{"id":2859329,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T00:02:18.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":1794167,"source":{"system":"sec-edgar","filing":"0001725160-21-000038","document":"wf-form4_161352010527706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000038/wf-form4_161352010527706.xml","form_type":"4"}},{"id":2882030,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-03T22:56:44.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":1300,"price":38.5446,"value":50107.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $38.50 to $38.55. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1750417,"source":{"system":"sec-edgar","filing":"0001725160-21-000023","document":"wf-form4_161239298598585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000023/wf-form4_161239298598585.xml","form_type":"4"}},{"id":2882029,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-03T22:56:44.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":12417,"price":37.6777,"value":467844.0009,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $37.50 to $38.10. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1751717,"source":{"system":"sec-edgar","filing":"0001725160-21-000023","document":"wf-form4_161239298598585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000023/wf-form4_161239298598585.xml","form_type":"4"}},{"id":2882028,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-03T22:56:44.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":13077,"price":37.2322,"value":486885.4794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $36.50 to $37.49. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1764134,"source":{"system":"sec-edgar","filing":"0001725160-21-000023","document":"wf-form4_161239298598585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000023/wf-form4_161239298598585.xml","form_type":"4"}},{"id":2916056,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":128309,"kind":"person","name":"SUN ANTHONY Y","position":1,"cik":"0001377952","reported_name":"SUN ANTHONY Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-07T01:25:41.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":6813,"price":53.0632,"value":361519.5816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.85 to $53.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1777211,"source":{"system":"sec-edgar","filing":"0001725160-21-000008","document":"wf-form4_160998272301109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000008/wf-form4_160998272301109.xml","form_type":"4"}}],"next_cursor":"2021-01-07T01:25:41.000000Z,2916056"}